medullary thyroid cancer

Type: Keyphrase

Name: medullary thyroid cancer

First Reported Mar 10 2010 - Updated Mar 10 2010 - 1 Documents

EXEL to Restructure, Cut 40% Staff

We're maintaining our fair value estimate for Exelixis EXEL after reviewing the firm's latest earnings results and corporate announcements. Fourth-quarter revenue rose to $44.1 million, compared to $29.6 million in the prior-year quarter, thanks to increased ... [Published Mar 10 2010 by Morningstar Canada]

Entities: Exelixis Inc, Lung Cancer, medullary thyroid cancer, glioblastoma

First Reported Feb 25 2010 - Updated Feb 26 2010 - 1 Documents

Food and Drug Administration

FDA Approved Diabetes Drug Despite Hints at Cancer Risk

The U.S. Food and Drug Administration (FDA) has defended its recent decision to approve the diabetes drug liraglutide (Victoza), though some animal research has suggested that it carries an increased risk of cancer. 'The relevance of the animal findings ... [Published Feb 25 2010 by AAPS Pharmceutica]

Entities: Food and Drug Administration, Diabetes, Liraglutide, Cancer

First Reported Feb 19 2010 - Updated Feb 19 2010 - 1 Documents

Liraglutide approved by FDA for treatment Type 2 diabetes

MedWire News: The US Food and Drug Administration (FDA) has approved the glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide for treatment of Type 2 diabetes, with some stipulations, including requests for further studies to assess possible safety ... [Published Feb 19 2010 by MedWire News]

Entities: Liraglutide, Food and Drug Administration, Diabetes, pancreatitis, medullary thyroid cancer

First Reported Feb 17 2010 - Updated Feb 18 2010 - 1 Documents

Market Report -- In Play (IMMU)

Immunomedics awarded patent for antibody therapy Co announced that U.S. patent 7,662,378 was issued covering the use of humanized, chimeric or human antibodies that bind to the carcinoembryonic antigen in combination with at least one other therapeutic ... [Published Feb 17 2010 by Briefing.com via MSN Money]

Entities: Cancer, Antibody, antibody therapy, medullary thyroid cancer

First Reported Jan 26 2010 - Updated Jan 26 2010 - 1 Documents

Novo Nordisk

FDA OKs Novo Nordisk Diabetes Drug

PRINCETON, N.J. (TheStreet) -- U.S. drug regulators approved late Monday a new once-daily injection for treating Type 2 diabetes made by the Danish drug maker Novo Nordisk(NVO Quote).More from Adam FeuersteinMarket ActivityNovo Nordisk A/S| NVOEli Lilly ... [Published Jan 26 2010 by TheStreet.com]

Entities: Novo Nordisk, Victoza, Diabetes, Food and Drug Administration

First Reported Oct 30 2009 - Updated Oct 30 2009 - 1 Documents

AstraZeneca PLC

AstraZeneca withdraws regulatory submissions for vandetanib in combo with chemotherapy for advanced NSCLC

AstraZeneca has withdrawn the regulatory submissions for the use of Zactima (vandetanib) 100mg in combination with chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) from the US FDA and the European Medicines Agency (EMEA). The ... [Published Oct 30 2009 by PharmaBiz]

Entities: Vandetanib, non-small cell lung cancer, Chemotherapy, AstraZeneca PLC

Quotes

"Liraglutide is an effective anti-diabetic drug, and controlling blood sugar in patients not adequately treated with other available therapies is very important in preventing the long-term complications of diabetes" she said

FDA Approved Diabetes Drug Despite Hints at Cancer Risk [EverydayHealth.com - Mar 17 2010]

More Content

sort by: Date \| Relevance
FDA Approved Diabetes Drug Despite Hints at Can... [EverydayHealth.com - Mar 17 2010]
Exelixis cuts workforce by 40% and XenoPort hal... [Pharma Times - Mar 10 2010]
EXEL to Restructure, Cut 40% Staff [Morningstar Canada - Mar 10 2010]
Restructuring Trends Continue in 2010: Exelixis... [Pharmacy Choice - Mar 10 2010]
Exelixis, Inc. Q4 2009 Earnings Call Transcript [Seeking Alpha - Mar 09 2010]
Exelixis to fire 270 workers [Biz Journals - Mar 08 2010]
FDA Approved Diabetes Drug Despite Hints at Can... [AAPS Pharmceutica - Feb 25 2010]
Liraglutide approved by FDA for treatment Type ... [MedWire News - Feb 19 2010]
FDA Approved Diabetes Drug Despite Hints at Can... [Yahoo! News - Feb 18 2010]
FDA Approved Diabetes Drug Despite Hints at Can... [Yahoo! News - Feb 18 2010]
Market Report -- In Play (IMMU) [Briefing.com via MSN Money - Feb 17 2010]
Novo Nordisk Makes Victoza(R) Commercially Avai... [PR Newswire via MSN Money - Feb 16 2010]
FDA OKs Novo Nordisk Diabetes Drug [TheStreet.com - Jan 26 2010]
AstraZeneca withdraws regulatory submissions fo... [PharmaBiz - Oct 30 2009]

Advanced Search Options